Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 9/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10750108 | 0.80 | CYP19A1 (0.52) | CYP19A1ALDH1A1GAAMAPTCYP1A2 | |
| SCHEMBL9182637 | 0.78 | ALDH1A1 (0.48) | CYP19A1ALDH1A1GAAMAPTCYP1A2 | |
| SCHEMBL48554 | 0.78 | AKR1B1 (0.61) | CYP19A1ALDH1A1GAAMAPTHSD17B10 | |
| SCHEMBL8040203 | 0.78 | CYP19A1 (0.50) | CYP19A1ALDH1A1GAAMAPTCYP1A2 | |
| SCHEMBL4662980 | 0.77 | FFAR1 (0.49) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| Potassium Ion SCHEMBL17653817 | 0.76 | CYP19A1 (0.48) | CYP19A1ALDH1A1GAAMAPTCYP1A2 | |
| Hydrochloric Acid SCHEMBL367129 | 0.76 | AKR1B1 (0.58) | CYP19A1ALDH1A1GAAMAPTHSD17B10 | |
| SCHEMBL6833334 | 0.76 | CYP19A1 (0.48) | CYP19A1ALDH1A1GAAMAPTLOXL2 | |
| Hydrochloric Acid SCHEMBL11097357 | 0.76 | AKR1B1 (0.58) | CYP19A1ALDH1A1GAAMAPTHSD17B10 | |
| SCHEMBL987989 | 0.76 | AKR1B1 (0.58) | CYP19A1ALDH1A1GAAMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4115646-A | Process for preparing 7-aminocephalosporanic acid derivatives | BEECHAM GROUP LIMITED (GB) | 1978-09-19 | — | — | US | claimed |
| US-20060058553-A1 | Novel bicyclic hydroxamates as inhibitors of histone deacetylase | AXYS PHARMACEUTICALS, INC. (US) | 2006-03-16 | — | — | US | disclosed |
| EP-1472216-A2 | NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | Axys Pharmaceuticals (US) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003066579-A2 | NOVEL BICYCLIC HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | AXYS PHARMACEUTICALS (US) | 2003-08-14 | — | — | WO | disclosed |
| US-4198406-A | Carbamoyl heterocyclicthio cephalosporins and pharmaceutical compositions formulated therewith | BEECHAM GROUP LIMITED (GB) | 1980-04-15 | — | — | US | disclosed |
| US-4115646-A | Process for preparing 7-aminocephalosporanic acid derivatives | BEECHAM GROUP LIMITED (GB) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058553-A1 | Novel bicyclic hydroxamates as inhibitors of histone deacetylase | HDAC1, HDAC2, HDAC11 | CYP19A1 2929/4885ALDH1A1 1478/4885GAA 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.